Citadel Advisors’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.86M Buy
2,065,411
+1,930,412
+1,430% +$10.8M 0.01% 3425
2025
Q4
$1.21M Sell
134,999
-2,169,454
-94% -$13.4M ﹤0.01% 6982
2025
Q3
$8.53M Sell
2,304,453
-3,228,523
-58% -$8.8M 0.01% 3500
2025
Q2
$10.8M Buy
5,532,976
+3,427,130
+163% +$7.14M 0.01% 2924
2025
Q1
$3.71M Sell
2,105,846
-72,116
-3% -$164K ﹤0.01% 4389
2024
Q4
$5.79M Sell
2,177,962
-580,397
-21% -$1.49M 0.01% 3727
2024
Q3
$6.32M Buy
2,758,359
+762,142
+38% +$2.32M 0.01% 3570
2024
Q2
$5.83M Sell
1,996,217
-103,378
-5% -$315K 0.01% 3516
2024
Q1
$7.64M Sell
2,099,595
-877,707
-29% -$1.69M 0.01% 3319
2023
Q4
$4.5M Buy
2,977,302
+527,446
+22% +$679K ﹤0.01% 3950
2023
Q3
$3.28M Buy
2,449,856
+38,175
+2% +$63.5K ﹤0.01% 4327
2023
Q2
$4.34M Sell
2,411,681
-448,189
-16% -$762K ﹤0.01% 3859
2023
Q1
$4.75M Sell
2,859,870
-2,455,161
-46% -$4.98M 0.01% 3913
2022
Q4
$10.2M Sell
5,315,031
-328,714
-6% -$665K 0.01% 2810
2022
Q3
$12.6M Buy
5,643,745
+21,510
+0.4% +$61.4K 0.02% 2425
2022
Q2
$18.2M Sell
5,622,235
-362,988
-6% -$1.58M 0.02% 1935
2022
Q1
$31.5M Buy
5,985,223
+480,952
+9% +$2.7M 0.04% 1500
2021
Q4
$46.8M Sell
5,504,271
-141,018
-2% -$1.3M 0.05% 1218
2021
Q3
$56.1M Sell
5,645,289
-756,400
-12% -$6.86M 0.06% 1038
2021
Q2
$57.9M Sell
6,401,689
-184,985
-3% -$2.11M 0.06% 1014
2021
Q1
$68.8M Buy
6,586,674
+4,086,050
+163% +$45.7M 0.07% 796
2020
Q4
$29.3M Buy
+2,500,624
New +$26M 0.03% 1415

Other funds holding NUVB